Frontlight ResearchEarly access
Bipolar disorder trials in Taiwan
1 of 2 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleNMDA Receptor Modulation for the Treatment of Bipolar I Disorder
- Where
- Taichung
- Age
- 18 years to 65 years
- People
- 90
- Run by
- China Medical University Hospital
See details and how to joinNCT05977023